ANI Pharmaceuticals, Inc.
ANIPNASDAQHealthcareDrug Manufacturers - Specialty & Generic

About ANI Pharmaceuticals

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. It markets, sells, and distributes its products through wholesalers, retail market chains, distributors and specialty pharmacies, group purchasing organizations, specialty pharmacies, hospitals, clinics, and physicians. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Phone218 634 3500
Address
210 Main Street West Baudette, Minnesota 56623 United States

Corporate Identifiers

CIK0001023024
CUSIP00182C103
ISINUS00182C1036
EIN58-2301143
SIC2834

Leadership Team & Key Executives

Nikhil Lalwani
President, Chief Executive Officer and Director
Stephen P. Carey
Senior Vice President of Finance and Chief Financial Officer
Meredith W. Cook J.D.
Senior Vice President, General Counsel and Corporate Secretary
Christopher K. Mutz
Senior Vice President and Head of Rare Disease
Ori Gutwerg
Senior Vice President of Generics
Muthusamy Shanmugam MS R.Ph.
Head of Research & Development, Chief Operating Officer of New Jersey Operations and Director
Elizabeth Powell J.D.
Chief Compliance Officer and Head of Legal of Rare Disease
Chad Gassert
Senior Vice President of Corporate Development and Strategy
Krista L. Davis
Senior Vice President and Chief Human Resources Officer
Dr. Mary Pao M.D., Ph.D.
Chief Medical Officer